In a filing, Nurix Therapeutics Inc revealed its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $68223.0 on Feb 16 ’24. In the deal valued at $10.02 per share,6,812 shares were sold. As a result of this transaction, van Houte Hans now holds 68,333 shares worth roughly $0.93 million.
Then, Hansen Gwenn sold 2,334 shares, generating $18,649 in total proceeds. Upon selling the shares at $7.99, the Chief Scientific Officer now owns 36,402 shares.
Before that, Ring Christine sold 1,760 shares. Nurix Therapeutics Inc shares valued at $14,063 were divested by the Chief Legal Officer at a price of $7.99 per share. As a result of the transaction, Ring Christine now holds 17,427 shares, worth roughly $0.24 million.
A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early March with a ‘”an Overweight”‘ rating. Oppenheimer began covering NRIX with “an Outperform” recommendation on February 28, 2023. Morgan Stanley started covering the stock on October 11, 2022. It rated NRIX as “an Equal-weight”.
Price Performance Review of NRIX
On Monday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock fall -0.07% to $13.58. Over the last five days, the stock has lost -12.16%. Nurix Therapeutics Inc shares have risen nearly 31.59% since the year began. Nevertheless, the stocks have risen 24.93% over the past one year. While a 52-week high of $18.12 was reached on 04/11/24, a 52-week low of $4.22 was recorded on 01/29/24. SMA at 50 days reached $13.18, while 200 days put it at $9.36. A total of 0.57 million shares were traded, compared to the trading of 1.49 million shares in the previous session.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 13.22, which if violated will result in even more drops to 12.86. On the upside, there is a resistance level at 14.02. A further resistance level may holdings at 14.46. The Relative Strength Index (RSI) on the 14-day chart is 46.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.73%. Stochastics %K at 15.25% indicates the stock is a buying.
